Literature DB >> 10411451

Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes.

T Bettinger1, J S Remy, P Erbacher.   

Abstract

Hepatocytes are interesting targets for gene therapy applications. Several hepatocyte-directed gene delivery vectors have been described. For example, simple galactosyl residues coupled to polyethylenimine (PEI) gave an efficient vector which selectively transfected hepatocytes via the asialoglycoprotein receptor-mediated endocytosis [Zanta, M. A., et al. (1997) Bioconjugate Chem. 8, 839-844]. However, the large size of these galactosylated PEI/DNA complexes prevented their use in vivo. We have investigated the role of the saccharide length on the size of glycosylated-PEI/DNA particles. When 5% of the PEI nitrogens were grafted with a linear tetragalactose structure (lGal4), small and stable particles were formed upon complexation with plasmid DNA. These particles were essentially toroids having a size of 50-80 nm and a zeta-potential close to neutrality. Moreover, these slightly charged PEI-lGal4/DNA complexes were as selective as the previously described galactosylated-PEI vector to transfect hepatocytes, but in addition, they were more efficient. It is expected that the properties of the PEI-lGal4/DNA complexes may increase their diffusion into the liver and their efficiency to transfect hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411451     DOI: 10.1021/bc990006h

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  16 in total

Review 1.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

2.  Topical application of plasmid DNA to mouse and human skin.

Authors:  Nuschin Meykadeh; Alireza Mirmohammadsadegh; Zhijun Wang; Etiena Basner-Tschakarjan; Ulrich R Hengge
Journal:  J Mol Med (Berl)       Date:  2005-05-19       Impact factor: 4.599

Review 3.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

4.  Synthetic PEGylated glycoproteins and their utility in gene delivery.

Authors:  Chang-po Chen; Ji-seon Kim; Dijie Liu; Garrett R Rettig; Marie A McAnuff; Molly E Martin; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2007 Mar-Apr       Impact factor: 4.774

5.  Engineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an example.

Authors:  Quinn K T Ng; Marie K Sutton; Pan Soonsawad; Li Xing; Holland Cheng; Tatiana Segura
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

Review 6.  Efficient siRNA delivery with non-viral polymeric vehicles.

Authors:  Won Jong Kim; Sung Wan Kim
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 7.  Polyethylene glycol-conjugated copolymers for plasmid DNA delivery.

Authors:  Minhyung Lee; Sung Wan Kim
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 8.  Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose.

Authors:  D T Klink; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

9.  Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid.

Authors:  Clark J Needham; Austin K Williams; Sue Anne Chew; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomacromolecules       Date:  2012-04-11       Impact factor: 6.988

Review 10.  Nano-vectors for efficient liver specific gene transfer.

Authors:  Atul Pathak; Suresh P Vyas; Kailash C Gupta
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.